NCT04589273 is a NA clinical trial of Alginate in Overweight and Obesity, sponsored by Newcastle University.

Who is sponsoring NCT04589273?

NCT04589273 is sponsored by Newcastle University.

What drugs are being tested in NCT04589273?

Interventions in NCT04589273: Alginate, Placebo.

What condition does NCT04589273 study?

NCT04589273 studies Overweight and Obesity.

Is NCT04589273 still recruiting?

NCT04589273 is currently status unknown. Last updated 1 June 2023.

Last reviewed 2023-06-01 · How we verify

NCT04589273

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Alginate Supplementation on Weight Management

Status unknown NA Last updated 1 June 2023

What this trial tests

NA trial testing Alginate in Overweight and Obesity in 190 participants. Status unknown.

Timeline

19 October 2020

Primary endpoint
31 October 2023

31 December 2023

Quick facts

Lead sponsor	Newcastle University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	basic science
Enrollment	190
Start date	19 October 2020
Primary completion	31 October 2023
Estimated completion	31 December 2023
Sites	1 location across United Kingdom

Drugs / interventions tested

Alginate — full drug profile →
Placebo

Conditions studied

Overweight and Obesity — all drugs for Overweight and Obesity →

Sponsor

Newcastle University

Who can join

18 and older, any sex, with Overweight and Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This project will assess the effect of the alginate (in a capsules) on the weight of generally healthy volunteers over a 12 week period. To achieve this, will recruit 150 (non-smoking) generally healthy volunteers to attend the study centre on four separate occasions. Volunteers will be randomly allocated into active or placebo arm of the trial, both will receive capsules with the same appearance. The volunteers will have their height, weight, waist circumference, body composition, and fasting levels of circulating glucose, triacylglycerol and cholesterol measured at each for the four visits.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Alginate

Trials testing the same drug.

NCT05629143 — Primary carE PPi dEprescRibing Trial · Phase 4 · active not recruiting
NCT05154461 — Intestinal Ketone Bodies Interfere With the Glycemic Control · NA · completed
NCT03635372 — A Comparison of Effectiveness of Oral Sucrolfate, Alginate and Hydrotalcide in Dispeptic Pain Treatment · Phase 4 · completed

Other recruiting trials for Overweight and Obesity

Currently open trials in the same condition.

NCT06282952 — Health Outcomes in C-Section Infants With Fecal Microbiota Transplantation · NA · recruiting
NCT07406191 — WB-EMS Effects on Cardiometabolic Risk Factors · NA · recruiting
NCT07230496 — A Study to Investigate Safety, Tolerability and Pharmacokinetics of LAE103 or LAE103 in Combination With LAE102 in Healt · Phase 1 · recruiting
NCT07313761 — A Trial to Compare the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered · Phase 1 · active not recruiting
NCT07165431 — Effect of a Postbiotic Supplementation in Overweight and Obese Subjects: A Randomized Controlled Trial (PARABIOTICS-2). · NA · recruiting

Other Newcastle University trials

Trials by the same sponsor.

NCT07206433 — Transient Ischemic Attack (TIA) and Spoken Language · not yet recruiting
NCT07128004 — In This Study, we Are Testing Whether Combining Two Interventions, in the Early Stages of Tinnitus, is More Effective in · NA · not yet recruiting
NCT06551012 — Neuromuscular Fatigability in Individuals With Heart Failure · NA · not yet recruiting
NCT07049874 — The Effect of Huel on Markers of Inflammation · NA · active not recruiting
NCT05713474 — Micro-EMG: A Novel Multi-electrode System for Intramuscular Imaging · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04589273 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Newcastle University
Last refreshed: 1 June 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04589273.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing